-
Signature
-
/s/ Avraham S. Adler, Attorney-in-Fact
-
Issuer symbol
-
PTCT
-
Transactions as of
-
24 Nov 2025
-
Net transactions value
-
-$1,745,118
-
Form type
-
4
-
Filing time
-
26 Nov 2025, 17:20:05 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Jacobson Allan Steven |
Director |
C/O PTC THERAPEUTICS, INC., 500 WARREN CORPORATE CENTER DRIVE, WARREN |
/s/ Avraham S. Adler, Attorney-in-Fact |
26 Nov 2025 |
0001579003 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
PTCT |
Common Stock |
Options Exercise |
$64,022 |
+5,701 |
+33% |
$11.23 |
23,152 |
24 Nov 2025 |
Direct |
F1 |
| transaction |
PTCT |
Common Stock |
Sale |
$456,821 |
-5,701 |
-25% |
$80.13 |
17,451 |
24 Nov 2025 |
Direct |
F1, F2 |
| transaction |
PTCT |
Common Stock |
Options Exercise |
$109,861 |
+6,100 |
+35% |
$18.01 |
23,551 |
24 Nov 2025 |
Direct |
F1 |
| transaction |
PTCT |
Common Stock |
Sale |
$488,915 |
-6,100 |
-26% |
$80.15 |
17,451 |
24 Nov 2025 |
Direct |
F1, F2 |
| transaction |
PTCT |
Common Stock |
Options Exercise |
$70,738 |
+6,299 |
+36% |
$11.23 |
23,750 |
25 Nov 2025 |
Direct |
F1 |
| transaction |
PTCT |
Common Stock |
Sale |
$187,074 |
-2,264 |
-9.5% |
$82.63 |
21,486 |
25 Nov 2025 |
Direct |
F1, F3 |
| transaction |
PTCT |
Common Stock |
Sale |
$210,664 |
-2,510 |
-12% |
$83.93 |
18,976 |
25 Nov 2025 |
Direct |
F1, F4 |
| transaction |
PTCT |
Common Stock |
Sale |
$95,006 |
-1,125 |
-5.9% |
$84.45 |
17,851 |
25 Nov 2025 |
Direct |
F1, F5 |
| transaction |
PTCT |
Common Stock |
Sale |
$34,096 |
-400 |
-2.2% |
$85.24 |
17,451 |
25 Nov 2025 |
Direct |
F1, F6 |
| transaction |
PTCT |
Common Stock |
Options Exercise |
$142,279 |
+7,900 |
+45% |
$18.01 |
25,351 |
25 Nov 2025 |
Direct |
F1 |
| transaction |
PTCT |
Common Stock |
Sale |
$203,147 |
-2,460 |
-9.7% |
$82.58 |
22,891 |
25 Nov 2025 |
Direct |
F1, F3 |
| transaction |
PTCT |
Common Stock |
Sale |
$291,997 |
-3,502 |
-15% |
$83.38 |
19,389 |
25 Nov 2025 |
Direct |
F1, F4 |
| transaction |
PTCT |
Common Stock |
Sale |
$104,574 |
-1,238 |
-6.4% |
$84.47 |
18,151 |
25 Nov 2025 |
Direct |
F1, F7 |
| transaction |
PTCT |
Common Stock |
Sale |
$59,724 |
-700 |
-3.9% |
$85.32 |
17,451 |
25 Nov 2025 |
Direct |
F1, F8 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
PTCT |
Stock Option (Right to Buy) |
Options Exercise |
$0 |
-5,701 |
-48% |
$0.000000 |
6,299 |
24 Nov 2025 |
Common Stock |
5,701 |
$11.23 |
Direct |
F1, F9 |
| transaction |
PTCT |
Stock Option (Right to Buy) |
Options Exercise |
$0 |
-6,100 |
-44% |
$0.000000 |
7,900 |
24 Nov 2025 |
Common Stock |
6,100 |
$18.01 |
Direct |
F1, F9 |
| transaction |
PTCT |
Stock Option (Right to Buy) |
Options Exercise |
$0 |
-6,299 |
-100% |
$0.000000 |
0 |
25 Nov 2025 |
Common Stock |
6,299 |
$11.23 |
Direct |
F1, F9 |
| transaction |
PTCT |
Stock Option (Right to Buy) |
Options Exercise |
$0 |
-7,900 |
-100% |
$0.000000 |
0 |
25 Nov 2025 |
Common Stock |
7,900 |
$18.01 |
Direct |
F1, F9 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: